MD3244F1 - Metoda de apreciere a agresivitatii cancerului endometrial - Google Patents

Metoda de apreciere a agresivitatii cancerului endometrial Download PDF

Info

Publication number
MD3244F1
MD3244F1 MDA20060139A MD20060139A MD3244F1 MD 3244 F1 MD3244 F1 MD 3244F1 MD A20060139 A MDA20060139 A MD A20060139A MD 20060139 A MD20060139 A MD 20060139A MD 3244 F1 MD3244 F1 MD 3244F1
Authority
MD
Moldova
Prior art keywords
endometrial cancer
determining
units
level
determined
Prior art date
Application number
MDA20060139A
Other languages
English (en)
Other versions
MD3244G2 (ro
Inventor
Dumitru Sofroni
Lilian GUTU
Katja Tenner
Anatolie CERNII
Corina Cardaniuc
Mihail Todiras
Michael Bader
Original Assignee
Institutia Medico-Sanitara Publica Institutul Oncologic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutia Medico-Sanitara Publica Institutul Oncologic filed Critical Institutia Medico-Sanitara Publica Institutul Oncologic
Priority to MDA20060139A priority Critical patent/MD3244G2/ro
Publication of MD3244F1 publication Critical patent/MD3244F1/ro
Publication of MD3244G2 publication Critical patent/MD3244G2/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la medicina, in special la oncologie si poate fi utilizata pentru aprecierea precoce neinvaziva a agresivitatii cancerului endometrial. Esenta inventiei consta in aceea ca se determina in tesuturile endometrial si miometrial nivelul de ARN mesager pentru triptofanhidroxilaza-1,si in cazul, in care nivelul constituie 0…15 unitati se determina o agresivitate majora, 16…400 unitati – o agresivitate medie, 400 unitati si mai mult se determina o agresivitate scazuta a cancerului endometrial.
MDA20060139A 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial MD3244G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Publications (2)

Publication Number Publication Date
MD3244F1 true MD3244F1 (ro) 2007-02-28
MD3244G2 MD3244G2 (ro) 2007-12-31

Family

ID=37845198

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060139A MD3244G2 (ro) 2006-05-15 2006-05-15 Metodă de apreciere a agresivităţii cancerului endometrial

Country Status (1)

Country Link
MD (1) MD3244G2 (ro)

Also Published As

Publication number Publication date
MD3244G2 (ro) 2007-12-31

Similar Documents

Publication Publication Date Title
MA31435B1 (fr) Inhibition de metastases tumorales par des anticoprs anti-neuropiline 2
EP3311818A3 (en) Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
CY1117784T1 (el) Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας
EP1904290A4 (en) MICRO BEADS ON ALUMINUM PHOSPHATE BASE
WO2007013950A3 (en) Combination therapy of her expressing tumors
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
EA200870029A1 (ru) Способ применения антагонистов il-6 с ингибиторами протеасом
CL2007003649A1 (es) Un conjugado de molecula asociado a anticuerpo monoclonal humano anti-cd70; composicion que comprende al conjugado de molecula asociado a anticuerpo; metodo de inhibicion del crecimiento de celulas tumorales que expresan cd70.
CO7160059A2 (es) Formulación líquida
MX2011006091A (es) Inhibidores de imidazopirazina syk.
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
WO2007051065A3 (en) Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
DE602004024374D1 (de) Zusammensetzungen zur verwendung als protein-kinase-inhibitoren
EP2499486A4 (en) COMPOSITIONS, KITS AND METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CANCER
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
WO2005008248A3 (en) Diagnosis and treatment of cervical cancer
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
EA200400029A1 (ru) КОМБИНАЦИЯ АНТАГОНИСТА РЕЦЕПТОРА АЛЬДОСТЕРОНА И ИНГИБИТОРА ГМГ-КоА-РЕДУКТАЗЫ
CY1116133T1 (el) Κλασματα θρομβοσπονδινης (thrombospondin) και χρησεις αυτων σε κλινικες δοκιμες για καρκινο και δημιουργια αντισωματων και αλλων παραγοντων συνδεσης
WO2008153543A3 (en) Fluorescent mouse model
UY27772A1 (es) Inhibidores triariloxiariloxipirimidin-2,4,6- triona de metaloproteinasa.
WO2006116016A3 (en) Molecular determinants of egfr kinase inhibitor response in glioblastoma
MD3244F1 (ro) Metoda de apreciere a agresivitatii cancerului endometrial
WO2010028313A3 (en) Phosphoprotein analysis of carcinomas for assessment of drug sensitivity

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees